These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
162 related items for PubMed ID: 8636652
1. Oral glutamine to prevent chemotherapy induced stomatitis: a pilot study. Skubitz KM, Anderson PM. J Lab Clin Med; 1996 Feb; 127(2):223-8. PubMed ID: 8636652 [Abstract] [Full Text] [Related]
2. The effect of oral glutamine on 5-fluorouracil/leucovorin-induced mucositis/stomatitis assessed by intestinal permeability test. Choi K, Lee SS, Oh SJ, Lim SY, Lim SY, Jeon WK, Oh TY, Kim JW. Clin Nutr; 2007 Feb; 26(1):57-62. PubMed ID: 16949180 [Abstract] [Full Text] [Related]
3. Oral glutamine reduces the duration and severity of stomatitis after cytotoxic cancer chemotherapy. Anderson PM, Schroeder G, Skubitz KM. Cancer; 1998 Oct 01; 83(7):1433-9. PubMed ID: 9762946 [Abstract] [Full Text] [Related]
4. A double-blind randomized placebo-controlled study of oral glutamine in the prevention of mucositis in children undergoing hematopoietic stem cell transplantation: a pediatric blood and marrow transplant consortium study. Aquino VM, Harvey AR, Garvin JH, Godder KT, Nieder ML, Adams RH, Jackson GB, Sandler ES. Bone Marrow Transplant; 2005 Oct 01; 36(7):611-6. PubMed ID: 16086046 [Abstract] [Full Text] [Related]
5. Phase III controlled evaluation of glutamine for decreasing stomatitis in patients receiving fluorouracil (5-FU)-based chemotherapy. Okuno SH, Woodhouse CO, Loprinzi CL, Sloan JA, LaVasseur BI, Clemens-Schutjer D, Swan D, Axvig C, Ebbert LP, Tirona MR, Michalak JC, Pierson N. Am J Clin Oncol; 1999 Jun 01; 22(3):258-61. PubMed ID: 10362332 [Abstract] [Full Text] [Related]
6. 5-fluorouracil and folinic acid-induced mucositis: no effect of oral glutamine supplementation. Jebb SA, Osborne RJ, Maughan TS, Mohideen N, Mack P, Mort D, Shelley MD, Elia M. Br J Cancer; 1994 Oct 01; 70(4):732-5. PubMed ID: 7917930 [Abstract] [Full Text] [Related]
7. Propantheline protects the oral mucosa after high-dose ifosfamide, carboplatin, etoposide and autologous stem cell transplantation. Oblon DJ, Paul SR, Oblon MB, Malik S. Bone Marrow Transplant; 1997 Dec 01; 20(11):961-3. PubMed ID: 9422475 [Abstract] [Full Text] [Related]
8. Influence of low-energy laser in the prevention of oral mucositis in children with cancer receiving chemotherapy. Cruz LB, Ribeiro AS, Rech A, Rosa LG, Castro CG, Brunetto AL. Pediatr Blood Cancer; 2007 Apr 01; 48(4):435-40. PubMed ID: 16862549 [Abstract] [Full Text] [Related]
9. Prophylaxis with GM-CSF mouthwashes does not reduce frequency and duration of severe oral mucositis in patients with solid tumors undergoing high-dose chemotherapy with autologous peripheral blood stem cell transplantation rescue: a double blind, randomized, placebo-controlled study. Dazzi C, Cariello A, Giovanis P, Monti M, Vertogen B, Leoni M, Tienghi A, Turci D, Rosti G, Nanni O, Rondoni C, Marangolo M. Ann Oncol; 2003 Apr 01; 14(4):559-63. PubMed ID: 12649101 [Abstract] [Full Text] [Related]
10. Misoprostol prophylaxis for high-dose chemotherapy-induced mucositis: a randomized double-blind study. Dueñas-Gonzalez A, Sobrevilla-Calvo P, Frias-Mendivil M, Gallardo-Rincon D, Lara-Medina F, Aguilar-Ponce L, Miranda-Lopez E, Zinser-Sierra J, Reynoso-Gomez E. Bone Marrow Transplant; 1996 May 01; 17(5):809-12. PubMed ID: 8733702 [Abstract] [Full Text] [Related]
11. Double-blinded, placebo-controlled trial on intravenous L-alanyl-L-glutamine in the incidence of oral mucositis following chemoradiotherapy in patients with head-and-neck cancer. Cerchietti LC, Navigante AH, Lutteral MA, Castro MA, Kirchuk R, Bonomi M, Cabalar ME, Roth B, Negretti G, Sheinker B, Uchima P. Int J Radiat Oncol Biol Phys; 2006 Aug 01; 65(5):1330-7. PubMed ID: 16765532 [Abstract] [Full Text] [Related]
12. Very intensive, short-term chemotherapy for children and adolescents with metastatic sarcomas. Felgenhauer J, Hawkins D, Pendergrass T, Lindsley K, Conrad EU, Miser JS. Med Pediatr Oncol; 2000 Jan 01; 34(1):29-38. PubMed ID: 10611582 [Abstract] [Full Text] [Related]
13. AIDS Clinical Trials Group Study 094: a phase I/II trial of ABV chemotherapy with zidovudine and recombinant human GM-CSF in AIDS-related Kaposi's sarcoma. Gill PS, Mitsuyasu RT, Montgomery T, Huang J, Cabriales S, Testa M, Espina BM, Levine AM, Miles SA. Cancer J Sci Am; 1997 Jan 01; 3(5):278-83. PubMed ID: 9327151 [Abstract] [Full Text] [Related]
14. Randomized, placebo-controlled trial of Saforis for prevention and treatment of oral mucositis in breast cancer patients receiving anthracycline-based chemotherapy. Peterson DE, Jones JB, Petit RG. Cancer; 2007 Jan 15; 109(2):322-31. PubMed ID: 17154160 [Abstract] [Full Text] [Related]
15. Oral glutamine to alleviate radiation-induced oral mucositis: a pilot randomized trial. Huang EY, Leung SW, Wang CJ, Chen HC, Sun LM, Fang FM, Yeh SA, Hsu HC, Hsiung CY. Int J Radiat Oncol Biol Phys; 2000 Feb 01; 46(3):535-9. PubMed ID: 10701731 [Abstract] [Full Text] [Related]
16. Concomitant administration of vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide for high-risk sarcomas: the St. Jude Children's Research Hospital experience. Navid F, Santana VM, Billups CA, Merchant TE, Furman WL, Spunt SL, Cain AM, Rao BN, Hale GA, Pappo AS. Cancer; 2006 Apr 15; 106(8):1846-56. PubMed ID: 16541446 [Abstract] [Full Text] [Related]
17. Intensive weekly combination chemotherapy for patients with intermediate-grade and high-grade non-Hodgkin's lymphoma. Sweetenham JW, Mead GM, Whitehouse JM. J Clin Oncol; 1991 Dec 15; 9(12):2202-9. PubMed ID: 1720454 [Abstract] [Full Text] [Related]
18. Phase I AIDS Clinical Trials Group (075) study of adriamycin, bleomycin and vincristine chemotherapy with zidovudine in the treatment of AIDS-related Kaposi's sarcoma. Gill PS, Miles SA, Mitsuyasu RT, Montgomery T, McCarthy S, Espina BM, Feldstein M, Levine AM. AIDS; 1994 Dec 15; 8(12):1695-9. PubMed ID: 7534090 [Abstract] [Full Text] [Related]
19. Peripheral blood stem cell support reduces the toxicity of intensive chemotherapy for children and adolescents with metastatic sarcomas. Hawkins DS, Felgenhauer J, Park J, Kreissman S, Thomson B, Douglas J, Rowley SD, Gooley T, Sanders JE, Pendergrass TW. Cancer; 2002 Sep 15; 95(6):1354-65. PubMed ID: 12216105 [Abstract] [Full Text] [Related]
20. Single-dose palifermin prevents severe oral mucositis during multicycle chemotherapy in patients with cancer: a randomized trial. Vadhan-Raj S, Trent J, Patel S, Zhou X, Johnson MM, Araujo D, Ludwig JA, O'Roark S, Gillenwater AM, Bueso-Ramos C, El-Naggar AK, Benjamin RS. Ann Intern Med; 2010 Sep 21; 153(6):358-67. PubMed ID: 20855800 [Abstract] [Full Text] [Related] Page: [Next] [New Search]